Company overview
Noramco specializes in the development and cGMP manufacturing of specialty active pharmaceutical ingredients (APIs), with a focus on controlled substances including opioids, stimulants, and cannabinoids. The company offers end-to-end solutions from narcotic raw materials and intermediates to multi-ton commercial supplies, supported by DEA-compliant processes in facilities across the United States and Europe. Additional services include custom synthesis, pre-formulation studies, particle sizing, stability assessments, and supply chain integration for pharmaceutical procurement and R&D.
Noramco is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include noramco api, controlled substance manufacturing, opioid api supplier, cgmp api production, pharma custom synthesis.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Noramco include Synthesis — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://noramco.com/
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- noramco api, controlled substance manufacturing, opioid api supplier, cgmp api production, pharma custom synthesis
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Noramco's core manufacturing capabilities for controlled substances?
- Noramco provides cGMP production of controlled-substance APIs from kilos to multi-ton scales, including opioids, stimulants like methylphenidate, and cannabinoids, with custom particle sizing and formulation support at facilities in the US (Delaware) and Europe.
- What regulatory compliance does Noramco offer?
- Noramco delivers DEA-compliant security and production for Schedule I to III substances, with comprehensive regulatory support, global regulatory footprint, and expertise in quality by design integrated into API development and manufacturing.
- What geographies does Noramco operate in?
- Noramco operates cGMP facilities in the United States (headquartered in Delaware) and Europe, sourcing from patented poppies via Tasmanian Alkaloids, and supplies world markets with high-purity APIs.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
